Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer. - Haderk F; Chou YT; Cech L; Fernández-Méndez C; Yu J; Olivas V; Meraz IM; Barbosa Rabago D; Kerr DL; Gomez C; Allegakoen DV; Guan J; et al. (Nature communications, 2024)